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Abstract The series of three 4-alkoxy-2-[2-hydroxy-3-
(4-aryl-1-piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]
pyridine-1,3(2H)-diones were synthesized. The structures
of all formed compounds were identified by elemental
analysis, FTIR, and 1H NMR. The synthesized compounds
were studied using differential scanning calorimetry and
thermogravimetric analysis in order to determine the
existence of multiple solid-state forms. Our measurements
showed that the solvent, mechanical treatment, and
quenching are the important factors. Two stable and one
metastable modification were detected. Additionally, DFT
calculations were performed.
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Introduction
The chemical structure of cyclic imides arouses great interest
in the scientific environment, as it creates the perfect base for
the creation of new groups of derivatives. Most of the
obtained derivatives can be characterized by anticonvulsant,
anxiolytic, serotoninergic, and antidepressive or antibacte-
rial activities. Moreover, many of the imides compounds
show local anesthetic, analgetic, and antiinflammatory
properties. Some of the derivatives are also inhibitors of the
enzymes that are important in physiological processes e.g.,
AR-aldose reductase or caspase-3 (inhibitors of caspase-3
have been described as promising cardioprotectants, neuro-
protectants, and antiarthritic agents) [1–7].
Some of the alkyl(heteroaryl)piperazinylalkyl deriva-
tives of cyclic imides show ‘‘pure’’ anxiolytic activity, e.g.,
Buspirone. These properties are the effect of their affinity to
5-HT1 receptor type. In order to obtain further information
concerning the correlation between chemical structure and
biological effects, many of the N-aminoalkyl derivatives of
3,4-pyridinedicarboximides were synthesized. Some of
them were tested in the pharmacological screening test, and
they have showed both the analgesic and antidepressant
activities, but not the anxiolytic ones [8]. Some of these
derivatives significantly suppress spontaneous locomotor
activity in mice, cause hypothermia in normothermic mice,
significantly decrease their amphetamine-induced hyperac-
tivity as well as display weak analgesic action [9]. During
the further research on these derivates, the structure of 1H-
pyrrolo[3,4-c]pyridine-1,3(2H)-diones have been modified.
These changes include mainly the introduction of alkoxy
(–OCH3 or –OC2H5) groups in the position two of pyridine
ring (Fig. 1) and of trifluoromethyl or methoxy groups into
the phenyl at N-4 of piperazine (Fig. 1, compound 2, 3).
Pharmacological studies indicate that after those modifica-
tions, new compounds revealed weaker analgetic activity. In
this paper, it is studied that the derivatives of 4-alkoxy-2-[2-
hydroxy-3-(4-aryl-1-piperazinyl)propyl]-6-methyl-1H-pyr-
rolo[3,4-c]pyridine-1,3(2H)-diones (Fig. 1) are non-toxic
(LD50 [ 2,000 mg kg
-1) with very strong analgesic prop-
erties. In the ‘‘hot plate’’ test, the compounds have showed
more potent analgesic activity than the acetylsalicylic acid
(ED50 11.9–96.8 mg kg
-1, for ASA 266.7 mg kg-1). Also
in the second test—‘‘writing syndrome’’ have displayed
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strong analgesic activity (ED50 0.4–1.35 mg kg
-1). It has
been interesting to observe that in this test, the investigated
imides have displayed superior activity to that, presented by
ASA and Morphine (two reference substances—ED50 for
ASA was 39.15 and for Morphine -2.44 mg kg-1) [10, 11].
On other hand, solid form diversity of pharmaceutical
substances may influence the efficacy and safety of drug
products. Physical and chemical characterization of dif-
ferent solid phases that may occur during crystallization
and pharmaceutical formulation processes, i.e. polymorphs,
pseudopolymorphism, solvates, desolvated solvates, and
amorphous materials, are advisable for both drugs and
excipients. It is very important to control the crystal form
of the drug during the various stages of drug development,
because any phase changes and difference in the degree of
crystallinity can alter the bioavailability of the drug.
Thermal analysis is one of the most frequently used
instrumental techniques on pharmaceutical researches
[12–16]. It is combined with other techniques, such as
FTIR, NMR, and XRD [17–23]. The main concept of this
work is to determine the thermal properties of three




The series of three 4-alkoxy-2-[2-hydroxy-3-(4-aryl-1-
piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,
3(2H)-diones were synthesized (Fig. 1). The starting
materials for the synthesized were 4-methoxy- and
4-ethoxy-6-methyl-1H-pyrrolo [3, 4] pyridine-1,3(2H)-di-
ones. Details of preparation are given in Ref. [10]. The
final compounds were crystallized from ethanol and tolu-
ene. Verification of the obtained compounds was carried
out by elemental analysis, IR, and 1H NMR spectroscopy.
1H NMR spectra was obtained on a Tesla 587 A spec-
trometer (80 MHz), when not indicated otherwise, using
TMS as an internal standard.
For NMR spectroscopy, the samples were prepared by
dissolving 5 mg of each form in 600 ll of CDCl3. The
NMR spectra all four compounds have characteristic sig-
nals of piperazine, benzene, and other protons. In NMR
spectrum of compound 1, we can see multiple signals of
piperazine four protons, three protons from CH3 (at
6-metylo), and two protons from –CH2 at 2.47–2.82 ppm
(m-9H, CH3, –CH2–N(CH2)2-). Other four protons
from piperazine are observed in signal at 3.13–3.25 ppm
(t-4H, -(CH2)2–N-benzene). Signals from two protons of
Ha-propyl are observed at 3.73–3.80 ppm (d-2H, -CH2 of
propyl). Multiple signals from OCH3 and Hb-propyl and
hydroxy group are recorded at 3.80–4.30 ppm (m-5H,
OCH3, -CH of propyl, -OH). And finally, multiple signals
of benzene‘s five protons and one proton from pyridine at
6.85–7.26 ppm are observed (m-6H, m-5H, arom., 1H
pyridine).
In NMR spectrum of compound 2, we can see multiple
signals of piperazine four protons, three protons from CH3
(at 6-metylo), and two protons from –CH2 at
2.45–2.70 ppm (m-9H, CH3, –CH2–N(CH2)2-). Other four
protons from piperazine are observed in signal at
3.00–3.20 ppm (t-4H, –(CH2)2–N–C6H4–m–CF3). Signals
from two protons of Ha-propyl are observed at
3.73–3.80 ppm (d-2H, –CH2 of propyl). Multiple signals
from OCH3 and Hb-propyl and hydroxy group are recorded
at 3.85–4.12 ppm (m-5H, OCH3, –CH of propyl, –OH).
And finally, multiple signals of benzene‘s four protons and
one proton from pyridine at 7.08–7.43 ppm are observed
(m-5H, arom., 1H pyridine).
In NMR spectrum of compound 3, we can see signal from
three protons of –ethoxy group at 1.43–1.47 ppm (t-3H,
-OCH2CH3). Multiple signals of piperazine four protons,
three protons from CH3 (at 6-metylo), and two protons from
–CH2 are observed at 2.57–2.71 ppm (m-9H, CH3, –CH2
–N(CH2)2-). Other four protons from piperazine are
observed in signal at 2.75–2.99 ppm (t-4H, –(CH2)2
–N–C6H4–o–OCH3). Multiple signals from OCH3, Ha, and
2Hb-propyl and hydroxy group (m-7H, –CH–CH2, –OH,
-C6H4–o–OCH3) at 3.82–4.04 ppm and signal from two















Fig. 1 1: 4-methoxy-2-[2-hydroxy-3-(4-phenyl-1-piperazinyl) pro-
pyl]-6-methyl-1H-pyrrolo [3,4-c] pyridine-1,3(2H)-dion, 2: 4-meth-
oxy-2-[2-hydroxy-3-(4-/m-trifluorophenyl-1-piperazinyl) propyl]-6-
methyl-1H-pyrrolo [3,4-c] pyridine-1,3(2H)-dion, 3: 4-ethoxy-2-[2-
hydroxy-3-(4-/o-methoxyphenyl-1-piperazinyl) propyl]-6-methyl-1H-
pyrrolo [3,4-c] pyridine-1,3(2H)-dion
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–OCH2CH3). And finally, multiple signals of benzene‘s four
protons and one proton from pyridine at 6.80–7.15 ppm are
observed (m-4H, arom., 1H pyridine).
Elemental analyses were run on a Carlo Erba NA 1500
analyser, and the results were within ±0.4 % of the values
calculated for the corresponding formulas. Elemental ana-
lysis confirms these free structures: compound 1
C22H26N4O4 : found: C, 66.43 %; H, 6.37 %; N, 13.70 %
(analytical: C, 64.39 %; H, 6.34 %; N, 13.66 %.), com-
pound 2 C23H25F3N4O4 : found: C, 57.45 %; H, 5.39 %; N,
11.38 % (analytical: C, 57.74 %; H, 5.23 %; N, 11.72 %.),
and compound 3 C24H30N4O5: found: C, 63.85 %; H,
6.42 %; N, 12.68 % (analytical: C, 63.44 %; H, 6.61 %; N,
12.33 %.).
Thermal analysis
The DSC traces were recorded on a Mettler Toledo DCS 25
measuring cell with TC15 TA Controller, calibrated with
indium to ensure the accuracy of the calorimetric scale.
Samples weighing 8–12 mg were characterized in sealed
40 lL aluminum pans with lids and subjected to ther-
mal analysis under a flowing argon atmosphere
(30 cm3 min-1). Analysis was carried out from room
temperature to about 20–30 degree above melting tem-
perature using heating rates of 5 K min-1 with an identical
empty sample pan as reference. The heat flow versus
temperature scans have been measured for samples
obtained from ethanol and toluene, after shock cooling and
after mechanical treatment. Thermogravimetric analysis
was performed by TG50 with Mettler Toledo Stare System.
The samples were placed in open alumina crucibles and
heating at the rate of 5 K min-1 under flowing argon
atmosphere (30 cm3 min-1).
FTIR
FTIR spectra were run on a Perkin-Elmer Spectrum Two
UATR FT-IR spectrometer. The samples were applied as
solids. Each spectrum was derived from 16 single averaged
scans collected in the region 450–4,000 cm-1 at a spectral
resolution of 2 cm-1.
Computational methods
Calculations were carried out using the GAUSSIAN 09
software package [24]. Density Functional Theoretical
(DFT) computations were performed using the closed shell
Becke–Lee–Yang–Parr hybrid exchange–correlation three-
parameter functional (B3LYP) [25–27] in combination
with 6-311 ? G (d,p) basis set.
Results and discussion
Studies on the thermal properties have been performed by
differential scanning calorimetry (DSC) and thermogravi-
metric analysis (TG). At the beginning, heat flow versus
temperature scans has been measured for samples obtained
from ethanol and toluene. In accordance with Ostwald’s
rule, the less stable modifications are often formed first on
the crystallizing process from the melt. These rearranged
then stepwise to the stable form. Quite often, it is easier to
obtain metastable forms by slowly heating amorphous
material (obtained by shock cooling from the melt) above
the glass transition temperature [28]. This procedure was
carried out next for all compounds. Sometimes metastable
form may be also generated by mechanical treatment. After
crystallization from ethanol, samples were grinded in a
mortar pestle, pressed, and then DSC experiment was
made. Additionally to determinate absence of solvates or
decomposition, the TG measurements were carried out.
The DSC scans for compound 1 are shown in Fig. 2. For
all runs, only one endothermic thermal effect, corresponds
to the melting, is observed. Temperature values are 462 K
(crystallization from ethanol), 462 K (crystallization from
toluene), and 462 K (after grinding and pressing). After a
shock cooling, the second measurement was carried out.
DSC trace shows only endothermic peak at 462 K. In TG
analysis, for all samples, no mass loss has indicated the
absence of solvate and decomposition process in investi-
gation temperature range (Fig. 2).
Temperature/K
after shock-cooling




























Fig. 2 DSC (solid) and TG (dash) traces at 5 K min-1 for compound 1
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The DSC scans for compound 2 are shown in Fig. 3. For
a first heating run, only one endothermic thermal effect is
observed. The temperature differs slightly, depending on
the type of sample. The melting temperature is 435 K for
sample crystallized from ethanol, 431 K for sample crys-
tallized from toluene. For sample which was grinded and
pressed, two thermal effects are observed: at 424 and
431 K. After a shock cooling and heating again, three
thermal effects are detected a single exothermic peak at
365 K due to cold crystallization and two endothermic
peaks at 424 and 431 K. In TG analysis, for all samples, no
mass loss up to 25 degree above melting temperature has
indicated the absence of solvate (Fig. 3). At higher tem-
perature (above melting), the decomposition is started.
The DSC scans for compound 3 are shown in Fig. 4.
One endothermic peak has been detected at 407 K (crys-
tallization from ethanol). For the sample crystallized from
toluene, the melting point is several degrees higher. The
value is 427 K. For sample which was grinded and pressed,
two thermal effects are observed: at 417 and 427 K. After a
shock cooling and heating again, the DSC trace shows
exothermic peak at 371 K (cold crystallization). On further
heating, two exothermic peaks, at 417 and 427 K, are
observed. In TG analysis, for all samples, no mass loss has
indicated the absence of solvate and decomposition process
in investigation temperature range (Fig. 4).
The FTIR spectra for all compounds are shown in
Figs. 5, 6, and 7. All molecules contain two imide carbonyl
groups and one hydroxy group. For compound 1, FTIR
spectra for various samples are identical (Fig. 5). The
carbonyl groups are recorded at 1,725 and 1,770 cm-1. The
stretching vibration of the hydroxyl group is observed at
3,380 cm-1. In the FTIR spectra of compound 2 (Fig. 6),
there are major differences between the spectra of samples.
In the region 3,500–2,600 cm-1, weak and broad bands are
observed. For the sample crystallized from toluene, a small
peak at 3,375 cm-1 is observed. This can be assigned to
stretching vibration of the hydroxyl group. For samples
crystallized from ethanol and after mechanical treatment,
weak and broad bands are assigned to stretching vibration
of the hydroxyl group involved in the hydrogen bonding,
which is superimposed on the C–H and Ar–H stretching
vibration. In the region 2,600–450 cm-1, the spectra of
three forms are reasonable similar. The carbonyl groups are
recorded at 1,720–1,770 cm-1. Small differences are
observed between 1,250 and 1,000 cm-1. Also for com-
pound 3 in the region 3,500–2,600 cm-1, there are major
differences between spectra of samples (Fig. 7). For the
sample crystallized from toluene, a small peak at
3,190 cm-1 is observed (–OH stretching vibration). For
other forms, hydroxyl group can be involved in H bonding.
In the region 2,600–450 cm-1, the spectra of three forms
are reasonably similar. The carbonyl groups are recorded at
1,722–1,775 cm-1. Small differences are observed between
1,400 and 1,150 cm-1.
Our results show that the type of solvent used for
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Fig. 3 DSC (solid) and TG (dash) traces at 5 K min-1 for compound 2
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Fig. 4 DSC (solid) and TG (dash) traces at 5 K min-1 for compound 3
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exists crystalline forms of a compound in which the solvent
molecules are included as an integral part of the structure,
is well known is in pharmaceutical industry. It should be
expected that packing of crystal may be different in polar
and nonpolar (ethanol and toluene) solvents or interaction
with ethanol molecules. However, it is interesting that the
solvent effect is not observed for compound 1.
We made a theoretical calculation of energy of inter-
action between title compounds and ethanol molecule.
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Fig. 5 Experimental FTIR
spectrum for various samples of
compound 1: crystallization
from ethanol, crystallization
from toluene, after mechanical
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Fig. 6 Experimental FTIR
spectrum for various samples of
compound 2: crystallization
from ethanol, crystallization
from toluene, after mechanical
treatment (from top to bottom)
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possible hydrogen bonding. The calculations show that for
compound 1, energy of interaction is positive: ?2.3 to
?2.53 kcal mol-1. For compounds 2 and 3, molecules with
substituted pyridine ring, energy of interaction via a
hydrogen bond is negative: -5.0 to -5.3 kcal mol-1
(compound 2) and -4.7 to -5.13 kcal mol-1
(compound 3). The distance between EtOHO is relatively
short: 1.82–1.95 A˚. Those results may indicate a high
probability of the intermolecular hydrogen bonding for
molecules with substituted pyridine ring.
Our results also indicate that compounds with substi-
tuted pyridine ring occur in three forms. Modification 1 is
formed during crystallization from ethanol. Modification 2
is formed during crystallization from toluene. Metastable
form 3 is formed after grinding and pressing and after
shock cooling and leads to stable form 2.
Conclusions
Three derivatives of 4-alkoxy-2-[2-hydroxy-3-(4-aryl-1-
piperazinyl)propyl]-6-methyl-1H-pyrrolo[3,4-c]pyridine-1,
3(2H)-diones were synthesized. The studied compounds are
the interesting materials due to their analgesic activity. The
differential thermal analysis (DSC) has been used to solid-
state characterization. Additionally, Density Functional
Theoretical (DFT) computations were performed. In phar-
maceutical industry, it is very important to control the purity
of crystal form. The aspect of our investigation was to
determine the existence of multiple solid-state forms. Our
measurements showed that the solvent, grinding, pressing,
and quenching are the important factors. It seems that a
compound 1 (with unsubstituted phenyl in phenylpiperazine
ring) probably exits in only one form. The m-substituted
derivative (compound 2) and the o-substituted derivative
probably occurs in two stable forms, crystalized from ethanol
and toluene, and metastable modification, formed after
during mechanical treatment and after shock cooling. The
theoretical calculation shows that only for compound 2 and
3, it is possible for hydrogen bonding with ethanol solvent.
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